Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Primary outcomes included cataracts, oculomotor binocular dysfunction, visual disturbances, dry eye disease, ametropic accommodative dysfunction, and visual issues with blindness, assessed through Cox proportional hazards models with Bonferroni correction
Do You Know
Other resolutions: 330 248 pixels | 960 720 pixels | 1,280 960 pixels | 3,840 2,880 pixels
In sum, GLP-1RAs have catalyzed a paradigm shift in obesity treatment, facilitating meaningful weight loss, fostering healthier dietary patterns, and prompting industry-wide adaptation
US$ 27.73
US$ 26.30
US$ 20.40
US$ 22.26
